Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

10th Oct 2012 17:35

RNS Number : 4319O
GlaxoSmithKline PLC
10 October 2012
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 9 October 2012 of the following increases in their notional interests in Ordinary Shares at a price of 1463 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $47.45 per ADS following the notional re-investment of the dividend paid to shareholders on 4 October 2012.

 

 

Ordinary Shares

ADSs

Sir Andrew Witty

17,794.388

Dr M M Slaoui

5,117.213

Mr S Dingemans

4,429.498

Mr S M Bicknell

1,816.043

Mr R G Connor

302.375

Mrs D P Connelly

2,425.568

Mr M Dunoyer

2,213.720

Mr S A Hussain

4,769.299

Mr W C Louv

1,493.576

Dr D Pulman

2,164.211

Mr D S Redfern

2,430.033

Ms C Thomas

3,427.023

Mr P C Thomson

685.338

Mr D E Troy

2,825.844

Dr P J T Vallance

4,181.492

Ms E Walmsley

2,780.409

Mr C Weber

605.483

Mrs V A Whyte

324.610

 

 

 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

10 October 2012

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQBLFFLBFXFBF

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77